A $220,000, one-year grant was awarded to ZenBio on March 15 by the National Institute on Aging, part of the National Institutes of Health. Through the Phase I Small Business Innovation Research grant, ZenBio will develop technology to use exosomes, or vesicles, secreted from stem cells to treat such age-related disorders as chronic tendon injuries, according to the Triange Business Journal.
“We know that there are aspects of stem cells that could have healing properties in the tendon area,” says Ben Buehrer, ZenBio vice president and co-principal investigator of the program. “Perhaps these exosomes and extracellular vesicles could also be useful in that area.”
ZenBio notes that tendon injuries impact half of people over the age of 60 and up to 80 percent of people over the age of 80, with current non-surgical treatment options showing mixed results and such injuries significantly hindering mobility and quality of life.
Read the full story at the Triange Business Journal.